Exempt Experiment Determination and Registrations will be reviewed by the IBC Chair, Vice-Chair, or his/her designee. Reviews are conducted on an on-going basis throughout the calendar year (no scheduled meetings). Protocols are reviewed in the order in which they are received.
Biohazardous Use Protocols will be reviewed by the IBC at a convened meeting. Reviews are scheduled on an as-needed basis throughout the calendar year.
For more information about IBC processes, see the IBC Policies and Procedures Manual, General Requirements and Procedures for Recombinant DNA Research, and Select Agents Procedures.